|
Cochlear
|
261.00 |
|
1.70 |
0.66% |
-18.15% |
2025-04-17 |
|
CSL
|
239.35 |
|
-2.54 |
-1.05% |
-11.81% |
2025-04-17 |
|
Ecofibre
|
0.02 |
|
0 |
0% |
-66.15% |
2025-04-17 |
|
Integral Diagnostics
|
2.25 |
|
-0.06 |
-2.60% |
-9.27% |
2025-04-17 |
|
Mesoblast
|
1.65 |
|
0.03 |
1.85% |
112.90% |
2025-04-17 |
|
Medical Developments International
|
0.45 |
|
-0.02 |
-3.23% |
-17.43% |
2025-04-17 |
|
Mayne Pharma
|
7.05 |
|
0.06 |
0.86% |
4.44% |
2025-04-17 |
|
Neuren Pharmaceuticals
|
10.53 |
|
0.36 |
3.54% |
-46.47% |
2025-04-17 |
|
Paradigm Biopharmaceuticals
|
0.29 |
|
-0.03 |
-7.94% |
1.75% |
2025-04-17 |
|
Pacific Edge
|
0.12 |
|
-0.003 |
-2.40% |
43.53% |
2025-04-17 |
|
Polynovo
|
1.12 |
|
0.06 |
5.19% |
-45.87% |
2025-04-17 |
|
PYC Therapeutics
|
1.03 |
|
-0.03 |
-2.37% |
8.42% |
2025-04-17 |
|
Ramsay Health Care
|
33.39 |
|
0.70 |
2.14% |
-33.99% |
2025-04-17 |
|
ResMed
|
33.61 |
|
0.57 |
1.73% |
21.64% |
2025-04-17 |
|
Sonic Healthcare
|
25.38 |
|
0.08 |
0.32% |
-2.05% |
2025-04-17 |